AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 8861829
Drug: PMEA (9-(2-phosphonylmethoxyethyl)adenine)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PMEA (9-(2-phosphonylmethoxyethyl)adenine) administered intravenously at a dose of 1000 mg weekly for 11 weeks
Trial: 1731046
Drug: Naloxone (0.05,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naloxone (0.05, 0.10, 0.15 and 0.20 mg)
Trial: 29897851
Drug: 0.9% sodium
RxNorm normalized name: LMD with 0.9% Sodium Chloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.9% sodium chloride content, rapid rate of administration
Trial: 29897851
Drug: 0.9% sodium
RxNorm normalized name: LMD with 0.9% Sodium Chloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.9% sodium chloride content, slow rate of administration
Trial: 29897851
Drug: 0.45% sodium
RxNorm normalized name: Dextrose 5% and 0.45% Sodium Chloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.45% sodium chloride content, rapid rate of administration
Trial: 29897851
Drug: 0.45% sodium
RxNorm normalized name: Dextrose 5% and 0.45% Sodium Chloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.45% sodium chloride content, slow rate of administration
Trial: 27132415
Drug: Piroxicam 10
RxNorm normalized name: piroxicam 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piroxicam 10 mg/day on days 4-6 after IUI
Trial: 20712131
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of oral activated charcoal (50 g) given 30 min after drugs
Trial: 20712131
Drug: Repeated doses
RxNorm normalized name: eicosyl povidone (2 eicosyl branches-repeat)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Repeated doses of oral activated charcoal (20 g) given 6-72 h after LTG
Trial: 20712131
Drug: Repeated doses
RxNorm normalized name: eicosyl povidone (2 eicosyl branches-repeat)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Repeated doses of oral activated charcoal (20 g) given 12-48 h after OXC
Trial: 10085281
Drug: Topical crude
RxNorm normalized name: COAL TAR,CRUDE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical crude honey (12 hourly application)
Trial: 2264899
Drug: Local anesthesia
RxNorm normalized name: Esters of benzoic acid for local anesthesia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local anesthesia with intravenous sedation (fentanyl, midazolam, or combinations thereof)
Trial: 2264899
Drug: Fentanyl, midazolam,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl, midazolam, and fentanyl/midazolam combinations as intravenous supplements
Trial: 6449360
Drug: Carbenicillin (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbenicillin (6 g/m(2) . 6 h) plus sisomicin (45 g/m2 . 6 h)
Trial: 6449360
Drug: Mezlocillin (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mezlocillin (3 g/m2 . 6 h) plus sisomicin (45 g/m2 . 6 h)
Trial: 16459230
Drug: 0.4 g/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.4 g/d of PSE in DAG-containing mayonnaise
Trial: 16459230
Drug: 0.3 g/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.3 g/d of PSE in DAG-containing mayonnaise
Trial: 11298175
Drug: Midazolam 0.04
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam 0.04 mg kg(‐1) (group 2)
Trial: 11298175
Drug: Midazolam 0.04
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam 0.04 mg kg(‐1) and lidocaine 1.5 mg kg(‐1) (group 3)
Trial: 11298175
Drug: Fentanyl 1
RxNorm normalized name: fentanyl 1.2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl 1 microg kg(‐1) and lidocaine 1.5 mg kg(‐1) (group 1)
Trial: 11298175
Drug: Midazolam 0.04
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam 0.04 mg kg(‐1) (groups 2 and 3)
Trial: 9392406
Drug: Inhaled salbutamol
RxNorm normalized name: salbutamol
DrugBank: Albuterol (DB01001)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Inhaled salbutamol (200 microg thrice daily for 14 days)
Trial: 9392406
Drug: Inhaled salbutamol
RxNorm normalized name: salbutamol
DrugBank: Albuterol (DB01001)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Inhaled salbutamol (600 microg single inhalation after 14 days treatment)
Trial: 9392406
Drug: Placebo (thrice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (thrice daily for 14 days)
Trial: 8017589
Drug: Propofol (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol (2.5 mg.kg‐1 b.w.)
Trial: 8017589
Drug: Thiopentone (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiopentone (5 mg.kg‐1 b.w.)
Trial: 8017589
Drug: Etomidate (0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etomidate (0.2 mg.kg‐1 b.w.)
Trial: 8017589
Drug: Flunitrazepam and
RxNorm normalized name: flunitrazepam
DrugBank: Flunitrazepam (DB01544)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flunitrazepam and fentanyl (0.005 mg.kg‐1 b.w.)
Trial: 2465099
Drug: Active antiarrhythmic
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active antiarrhythmic therapy (various drugs including encainide and flecainide)
Trial: 2465099
Drug: Encainide and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Encainide and flecainide treatments
Trial: 2465099
Drug: Active therapies
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active therapies (general)
Trial: 62111
Drug: Warfarin sodium
RxNorm normalized name: Warfarin Sodium
DrugBank: Warfarin (DB00682)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Warfarin sodium (doses aimed at maintaining a 'Thrombotest' value of 10%, given from the day of admission until independent mobility or for 3 months)
Trial: 31444192
Drug: Treatment as
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment as usual with a wearable device
Trial: 26279111
Drug: L-T4 treatment
RxNorm normalized name: L-T4
DrugBank: Levothyroxine (DB00451)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: L-T4 treatment (1.6 µg/kg daily)
Trial: 23430723
Drug: Specific antibiotics
RxNorm normalized name: Pacific halibut
DrugBank: Pacific halibut (DB10616)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Specific antibiotics (Group A)
Trial: 23430723
Drug: No specific
RxNorm normalized name: Oregano specific IgE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No specific antibiotics (Group B)
Trial: 18257346
Drug: Pricking blood
RxNorm normalized name: dragon's blood extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pricking blood therapy combined with acupuncture
Trial: 18257346
Drug: Routine western
RxNorm normalized name: western larch pollen extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine western medicine (Aciclovir plaster and Aciclovir tablets)
Trial: 17846273
Drug: Isotonic sodium
RxNorm normalized name: ISOTONIC SODIUM CHLORIDE SOLUTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isotonic sodium chloride solution (placebo)
Trial: 11495138
Drug: Active dental
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active dental gel (lidocaine 25 mg/g plus prilocaine 25 mg/g)
Trial: 9728853
Drug: Oral antihistamines
RxNorm normalized name: Ahist Antihistamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral antihistamines (diphenhydramine ≤ 1 mg/kg and cimetidine ≤ 4 mg/kg)
Trial: 29663959
Drug: 4-drug fixed-dose
RxNorm normalized name: 4-MIXED TRACE ELEMENTS INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4-drug fixed-dose combination (4FDC)
Trial: 29663959
Drug: 2-drug fixed-dose
RxNorm normalized name: ALLERGENIC EXTRACT, 2 GRASS MIX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2-drug fixed-dose combination (2FDC)
Trial: 29663959
Drug: Single-drug reference
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-drug reference
Trial: 14499320
Drug: Topiramate (TPM)
RxNorm normalized name: Topiramate
DrugBank: Topiramate (DB00273)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Topiramate (TPM) as monotherapy (n=7) or adjunctive therapy to carbamazepine (CBZ) (n=2) at dosages ranging from 25 mg to 100 mg twice daily
Trial: 10707873
Drug: rHuIL-12 (higher
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rHuIL-12 (higher doses)
Trial: 28459732
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (fluid therapy based on traditional principles)
Trial: 26242578
Drug: Metformin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin (500 mg twice daily, increased to 1000 mg twice daily over 6 weeks)
Trial: 21690510
Drug: Fluticasone furoate
RxNorm normalized name: Fluticasone Furoate
DrugBank: Fluticasone furoate (DB08906)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fluticasone furoate nasal spray, 55 μg/nostril daily for 2 weeks
Trial: 17205943
Drug: Standard therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard therapy plus epidural injection of 80 mg methylprednisolone and 10 mg bupivacaine
Trial: 17205943
Drug: Standard therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard therapy (oral antiviral agents and analgesics) alone
Trial: 10960626
Drug: Raloxifene 150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Raloxifene 150 mg/day
Trial: 14610642
Drug: HRT (Premarin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HRT (Premarin 0.625 mg/day, and Provera 2.5 mg/day)
Trial: 2890150
Drug: Famotidine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Famotidine (20 mg at night)
Trial: 2890150
Drug: Ranitidine (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine (300 mg at night)
Trial: 2890150
Drug: All drugs
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All drugs (Famotidine and Ranitidine)
Trial: 29707200
Drug: Simvastatin administration
RxNorm normalized name: Simvastatin
DrugBank: Simvastatin (DB00641)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Simvastatin administration
Trial: 27841968
Drug: Low-Level Laser
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-Level Laser Therapy (LLLT) applied at 10 points through the surgical scar in three sessions.
Trial: 22534479
Drug: PE+MARS treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PE+MARS treatment
Trial: 20862935
Drug: Western medication
RxNorm normalized name: Western wheatgrass
DrugBank: Pascopyrum smithii pollen (DB10719)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Western medication (Captopril)
Trial: 18187817
Drug: Hydroxychloroquine 200
RxNorm normalized name: hydroxychloroquine 200 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydroxychloroquine 200 mg twice daily for the first month and 200 mg once daily for the next month (total duration 2 months)
Trial: 18187817
Drug: Chloroquine 250
RxNorm normalized name: chloroquine 250 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chloroquine 250 mg twice daily for the first month and 250 mg once daily for the next month (total duration 2 months)
Trial: 12940470
Drug: Preparing for
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preparing for the Drug Free Years Program (PDFY)
Trial: 10485271
Drug: Interferon-alpha (IFN-alpha)
RxNorm normalized name: Interferon alpha-2B
DrugBank: Interferon alfa-2b (DB00105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interferon-alpha (IFN-alpha) administered 2 h before cyclophosphamide (CP)
Trial: 10485271
Drug: Interferon-alpha (IFN-alpha)
RxNorm normalized name: Interferon alpha-2B
DrugBank: Interferon alfa-2b (DB00105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interferon-alpha (IFN-alpha) administered 24 h after cyclophosphamide (CP)
Trial: 7815355
Drug: Naproxen (oral)
RxNorm normalized name: Naproxen
DrugBank: Naproxen (DB00788)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Naproxen (oral)
Trial: 7815355
Drug: Tenidap (oral)
RxNorm normalized name: tenidap
DrugBank: Tenidap (DB13481)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tenidap (oral)
Trial: 1657084
Drug: Perindopril (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perindopril (2 mg)
Trial: 7104466
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg dose of chlorothiazide
Trial: 7104466
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg dose of chlorothiazide
Trial: 7104466
Drug: 250 mg
RxNorm normalized name: rutin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg dose of chlorothiazide
Trial: 29030775
Drug: Prednisolone treatment
RxNorm normalized name: Prednisolone
DrugBank: Prednisolone acetate (DB15566)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prednisolone treatment for three cycles of 21 days
Trial: 22518827
Drug: 10 mM
RxNorm normalized name: potassium 10 MMOL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mM l‐NAME
Trial: 22518827
Drug: Combined 10
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined 10 mM l‐NAME + 20 mM capsazepine
Trial: 12507112
Drug: High-dose irradiation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose irradiation (mean margin dose of 52.1 Gy)
Trial: 12507112
Drug: Low-dose irradiation
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose irradiation (mean margin dose of 41.5 Gy)
Trial: 9578044
Drug: Extended-release carbamazepine
RxNorm normalized name: carbamazepine Extended Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended-release carbamazepine (CBZ) twice daily
Trial: 9578044
Drug: Immediate-release carbamazepine
RxNorm normalized name: carbamazepine Extended Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate-release carbamazepine (CBZ) four times daily
Trial: 33086
Drug: Naproxen sodium
RxNorm normalized name: Naproxen Sodium
DrugBank: Naproxen (DB00788)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Naproxen sodium (550 mg at first sign of pain, then 275 mg every six hours as needed)
Trial: 23031209
Drug: Group-housed (G)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group-housed (G)
Trial: 11554706
Drug: Moisturising cream
RxNorm normalized name: capsaicin Topical Cream [Arthricare for Women Moisturizing]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moisturising cream applied for 14 days
Trial: 9255718
Drug: Chitosan (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chitosan (30 tablets, 45 mg/tablet, three times a day)
Trial: 9255718
Drug: Control treatment
RxNorm normalized name: SALICYLIC ACID 190 mg in 1 mL TOPICAL LIQUID [Derma E Acne Blemish Control Treatment Serum]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control treatment (1 week prior to chitosan ingestion)
Trial: 8332651
Drug: Clonidine 0.3
RxNorm normalized name: CLONIDINE 0.3MG/24HR PATCH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine 0.3 mg b.d. for two weeks
Trial: 3089439
Drug: Prednisolone (steroids)
RxNorm normalized name: Prednisolone
DrugBank: Prednisolone acetate (DB15566)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prednisolone (steroids) for 3 days
Trial: 24595149
Drug: 3 ml
RxNorm normalized name: WATER,INHL 3 ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 ml (15 mg) 0.5% isobaric levobupivacaine (group L)
Trial: 24595149
Drug: 3 ml
RxNorm normalized name: WATER,INHL 3 ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 ml (15 mg) of 0.5% hyperbaric bupivacaine (group B)
Trial: 21929835
Drug: EPA (1·67
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EPA (1·67 g EPA + 0·16 g DHA/d)
Trial: 21929835
Drug: DHA (1·55
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DHA (1·55 g DHA + 0·40 g EPA/d)
Trial: 21929835
Drug: LA (2·2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LA (2·2 g/d)
Trial: 20197484
Drug: Necitumumab 800
RxNorm normalized name: necitumumab 800 MG in 50 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Necitumumab 800 mg (flat dosing)
Trial: 20197484
Drug: Necitumumab 600
RxNorm normalized name: Necitumumab
DrugBank: Necitumumab (DB09559)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Necitumumab 600 mg or more
Trial: 20197484
Drug: Necitumumab 1000
RxNorm normalized name: Necitumumab
DrugBank: Necitumumab (DB09559)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Necitumumab 1000 mg every 2 weeks
Trial: 18806204
Drug: Topically applied
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topically applied NTG ointment (2%)
Trial: 18806204
Drug: Topically applied
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topically applied NTG ointment (2%) + treadmill ambulation
Trial: 16894463
Drug: Ticlopidine 250
RxNorm normalized name: ticlopidine 250 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ticlopidine 250 mg daily (before July 1999) or Clopidogrel 75 mg daily (after July 1999) for one month
Trial: 8851903
Drug: Diuretic plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diuretic plus exercise training (D+E)
Trial: 6647208
Drug: metoprolol (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: metoprolol (all formulations)
Trial: 31203725
Drug: Nilvadipine treatment
RxNorm normalized name: nilvadipine
DrugBank: Nilvadipine (DB06712)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nilvadipine treatment
Trial: 20646099
Drug: Cholecalciferol 1,000
RxNorm normalized name: CHOLECALCIFEROL 1,000UNIT CAP,ORAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholecalciferol 1,000 IU/day (daily D(3) group)
Trial: 15754269
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg of modified‐release aspirin daily
Trial: 15754269
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg of simvastatin daily
Trial: 7023526
Drug: SHRZ6 and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SHRZ6 and EHRZ6 regimens (6 months, daily isoniazid and rifampicin, supplemented by streptomycin and pyrazinamide for the first two months)
Trial: 7023526
Drug: EHR9 regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EHR9 regimen (9 months, daily isoniazid and rifampicin, supplemented by ethambutol for the first two months)
Trial: 7023526
Drug: SHRZ6 and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SHRZ6 and EHRZ6 regimens (6 months, daily isoniazid and rifampicin, supplemented by pyrazinamide)
Trial: 7023526
Drug: EHR9 regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EHR9 regimen (9 months, daily isoniazid and rifampicin, supplemented by ethambutol)
Trial: 30918097
Drug: Trofinetide 200
RxNorm normalized name: trofinetide 200 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trofinetide 200 mg/kg bid
Trial: 27300156
Drug: Contrast treatment
RxNorm normalized name: Contrased
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Contrast treatment
Trial: 25195684
Drug: Extracorporeal liver
RxNorm normalized name: LIVER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extracorporeal liver support therapy
Trial: 17767632
Drug: Tidal volume
RxNorm normalized name: VOLUME EXPANDERS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tidal volume breathing using an O(2) flow of 9 l x min(‐1) for 3 min (TV x 3 min)
Trial: 17767632
Drug: Four deep
RxNorm normalized name: Four-Way
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Four deep breaths within 30 s using an O(2) flow of 15 l x min(‐1) (4 DB)
Trial: 17767632
Drug: Eight deep
RxNorm normalized name: Deep Sea
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eight deep breaths within 1 min using an O(2) flow of 15 l x min(‐1) (8 DB)
Trial: 15554760
Drug: Lamotrigine (target
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lamotrigine (target dose = 200 mg/day, minimum dose = 100 mg/day)
Trial: 11592671
Drug: Dextroamphetamine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dextroamphetamine (10 mg)
Trial: 11592671
Drug: Dextroamphetamine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dextroamphetamine (10 mg) under no fatigue
Trial: 7842531
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil supplementation (3 gm EPA and 2 gm DHA daily)
Trial: 3585610
Drug: PMN transfusions
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PMN transfusions (15 mL/kg containing 0.5 to 1.0 X 10(9) PMN, one transfusion every 12 hours for a total of five transfusions)
Trial: 7774757
Drug: Sodium bicarbonate
RxNorm normalized name: Sodium Bicarbonate
DrugBank: Sodium bicarbonate (DB01390)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium bicarbonate (4 to 6 g/day)
Trial: 7774757
Drug: High-lipase pancreatin
RxNorm normalized name: amylase / lipase / pancreatin / protease
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-lipase pancreatin (9 g/day)
Trial: 7774757
Drug: Commercial pancreatic
RxNorm normalized name: Pancreatin
DrugBank: Pancrelipase (DB00085)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Commercial pancreatic enzyme preparations (12 to 24 tablets or 9.0 g)
Trial: 7774757
Drug: Omeprazole (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole (50 mg)
Trial: 1964664
Drug: Subcutaneous fixed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous fixed doses of a low‐molecular‐weight heparin (CY216; 225 IC anti‐Xa U/kg 12 hourly) for 10 days
Trial: 1964664
Drug: Intravenous adjusted
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous adjusted unfractionated heparin (UFH)
Trial: 31369185
Drug: l-carnitine (LC)
DrugBank: Levocarnitine (DB00583)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: l-carnitine (LC) supplementation 2 g for 8 weeks
Trial: 23842215
Drug: Midodrine (12.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midodrine (12.5 mg 3 times/d; over 3 d)